Lv41
800 积分 2025-10-16 加入
Engineering and targeting potential of CAR NK cells in colorectal cancer
1小时前
待确认
NKG2A inhibition promotes NK cell-CD8+ T cell interactions to improve anticancer immunity in ovarian carcinoma
1小时前
待确认
PARP Inhibitors Differentially Regulate Immune Responses in Distinct Genetic Backgrounds of High-Grade Serous Tubo-Ovarian Carcinoma
1小时前
待确认
53BP1 loss elicits cGAS-STING-dependent antitumor immunity in ovarian and pancreatic cancer
1小时前
待确认
Harnessing STING Signaling and Natural Killer Cells Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Breast Cancer
1小时前
待确认
Epithelial ovarian cancer
1个月前
已完结
Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector Treg cells for homologous-recombination-deficient tumors
1个月前
已完结
Mapping spatial organization and genetic cell-state regulators to target immune evasion in ovarian cancer
2个月前
已完结
Harnessing STING Signaling and Natural Killer Cells Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Breast Cancer
2个月前
已完结
Laparoscopic Cytoreduction After Neoadjuvant Chemotherapy in High-Grade Epithelial Ovarian Cancer
4个月前
已完结
皖公网安备34019202002308
